Verimatrix Launches XTD Velocity Partner Alliance to Accelerate Global Channel Sales
Risk Associates, a Middle East leader, joins the partner program to drive Verimatrix XTD app protection, threat detection & Response managed services to their customers
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix XTD Velocity Partner Alliance, a global channel sales program designed to empower partners with best-in-class application protection solutions. As part of this initiative, Risk Associates, a leading Managed Security Services Provider (MSSP), has joined the program to offer Verimatrix XTD Enterprise Suite to banks and enterprises across Australia, Bahrain, Saudi Arabia, and the UAE.
The XTD Velocity Partner Alliance, spearheaded by Simon Emery, Global Head of Strategic Partnerships at Verimatrix, provides resellers, MSSPs, system integrators, and cybersecurity firms with comprehensive resources to deliver AI-powered mobile app shielding, endpoint threat detection, and response solutions. The program enhances channel sales by offering:
- Resell XTD & Deliver Managed Services – Offer 24/7 app hardening with AI-driven threat detection to stop cyberattacks.
- Expert Training & Certification – Gain the skills to deploy and integrate Verimatrix XTD with confidence.
- Marketing & Sales Power – Access co-branded campaigns, deal registration, and exclusive marketing funds.
- Innovate & Collaborate – Partner on cutting-edge security solutions through joint development and certification.
“With the Verimatrix XTD Velocity Partner Alliance, we're redefining how cybersecurity providers and channel partners collaborate to accelerate app protection at scale,” said Jon Samsel, Global Head of Cybersecurity Business at Verimatrix. “Our expanded partnership with Risk Associates has already resulted in six banks choosing Verimatrix to safeguard their applications—and we’re just getting started. Strategic alliances like this ensure that financial institutions can leverage our award-winning technologies to protect their app code, customer data, and brand reputation with confidence.”
Having successfully deployed Verimatrix XTD app protection for fintech and banking institutions since last year, Risk Associates brings over 20 years of cybersecurity expertise and serves as a trusted MSSP for top brands and startups across the region.
It’s dedication to shielding businesses from the latest threats, including mobile-based attacks, matches well with the opportunity to offer its customers the Verimatrix XTD suite that powerfully protects mobile app owners from reverse engineering, application repackaging attacks, dynamic modification, man-in-the-device attacks while also providing anti-Frida, anti-emulator and anti-debugger defenses.
“Risk Associates welcomes this partnership with Verimatrix to offer proven protections for vital mobile apps that are relied upon by millions in the regions we serve,” said Aziz A. Rahim, Chief Operating Officer at Risk Associates. “Verimatrix’s powerful yet easily-to-implement XTD technologies provide tremendous value to customers through extensive threat visibility and remediation that is often lacking in vulnerable apps that remain crucial for enterprises and their users.”
As part of the XTD Velocity Partner Alliance, Risk Associates now offers the following Verimatrix XTD platform solutions:
Verimatrix XTD Enterprise includes:
- XTD Protect for iOS
- XTD Protect for Android
- XTD Detection & Response
Additional Verimatrix solutions available for resale include:
- XTD Protect for Desktop/Embedded
- XTD Protect for Web
- XTD Protect Native for iOS
- XTD Protect Native for Android
- XTD Managed Services
For more information on joining the Verimatrix XTD Velocity Partner Alliance, visit https://www.verimatrix.com/partners.
About Risk Associates
At Risk Associates, our passion is simplifying compliance for organizations in an increasingly complex regulatory environment. As a UKAS-accredited certification body, we specialize in offering certifications and assessments that enable businesses to meet international standards, minimize risks, and safeguard their operations. We take pride in our role as PCI GEAR (Global Executive Assessor Roundtable) Advisors, ranking among the top 30 QSA companies globally.
Risk Associate’s industry recognition, encompassing PCI DSS, PCI PIN, PCI P2PE, PCI TSP, PCI SSF, PCI SSLC, PCI ASV, PCI 3DS, CSA STAR, SOC I and II, ISO/IEC 27001, ISO/IEC 27701, ISO/IEC 22301, ISO/IEC 20000, HIPAA, HITRUST, GDPR, SWIFT, MARS-E, and NIST, serves as a testament to our expertise, knowledge and compliance competence. As a Qualified Security Assessor (PCI-QSA) company approved by the Payment Card Industry (PCI) Security Standards Council, we are acknowledged as an industry leader specializing in cybersecurity, compliance, information governance, strategy and training. Our services extend across Australia, Europe, the Middle East, Asia Pacific and North America. Visit www.riskassociates.com. Visit www.riskassociates.com.
About Verimatrix
Verimatrix (Euronext Paris: VMX, FR0010291245) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure premium movies, live streaming sports, sensitive financial and healthcare data, mission-critical mobile applications, and much more. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319818660/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom